President & CEO of Beech Tree Labs seeks FDA approval for TML COVID-19 treatment


DELANSON, N.Y. (NEWS10) — Beech Tree Labs President & CEO, Dr. John McMichael, believes a product called TML could be used to tackle COVID-19. 

It was developed decades ago and has even been through FDA phase 2-trials for patients with herpes. 

According to Dr. McMichael, COVID-19 patients who received TML recovered within 48 hours. His next step in getting the treatment approved is a pilot trial. 

“We are planning on doing two trials, the first is a pilot trial.  It will be a 40-patient study. 20 patients get the placebo and 20 patients get the TML. The agency has what’s called an emergency use authorization. (The agency being the FDA.) If our pilot trial is successful, it is our understanding that even while our phase 3 trial is underway, TML can be distributed right away to people in need,” said Dr. John McMichael, Beech Tree’s President & CEO.  

Assemblyman Chris Tague is also on board and recently sent a letter to the White House highlighting Dr. McMichael’s efforts.  

County-by-county Coronavirus Tracker
Watch Updates from Officials
COVID-19 Resources
Reopening New York
More Coronavirus Coverage from News10


Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Click Below to set up your cable box

No Neighbor Hungry Campaign

Download our news app

App Store Link
Google Play Link

Coronavirus Outbreak

More Coronavirus Outbreak

Classroom Progress Report

More Classroom Progress Report

10 in Toga